#news #biotech GV names ex-Agios CEO David Schenkein as general partner

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: GV names ex-Agios CEO David Schenkein as general partner .Former Agios Pharmaceuticals CEO David Schenkein has joined the life science investing team at GV. Schenkein will co-lead the life science team at the fund, formerly known as Google Ventures, with Krishna Yeshwant.

from FierceBiotech: Biotech http://bit.ly/2TM8yez